H

C

HENNEQUIN , C.

Last name: HENNEQUIN

First name: C.

October 1, 2017 (v1)

Journal article

Metadata-only

Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer

Azria, D. Doyen, J. Jarlier, M.

BackgroundOutcome of intermediate risk rectal cancer may be improved by the addition of oxaliplatin during 5-fluoruracil concomitant neoadjuvant chemoradiotherapy. The purpose of this study is to analyze the main clinical results of the ACCORD12 trial (NCT00227747) in rectal cancer after 5 years of follow-up.Patients and methodsInclusion...

Uploaded on: March 26, 2023